Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-017-13431-y.pdf
Reference37 articles.
1. Jamieson, E. R. & Lippard, S. J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chemical reviews 99, 2467-2498 (1999).
2. Brozovic, A. & Osmak, M. Activation of mitogen-activated protein kinases by cisplatin and their role in cisplatin-resistance. Cancer letters 251, 1–16, https://doi.org/10.1016/j.canlet.2006.10.007 (2007).
3. Kishida, S. & Kadomatsu, K. Involvement of midkine in neuroblastoma tumourigenesis. Br J Pharmacol 171, 896–904, https://doi.org/10.1111/bph.12442 (2014).
4. Jones, D. R. Measuring midkine: the utility of midkine as a biomarker in cancer and other diseases. Br J Pharmacol 171, 2925–2939, https://doi.org/10.1111/bph.12601 (2014).
5. Zhang, H., Okamoto, M., Panzhinskiy, E., Zawada, W. M. & Das, M. PKCdelta/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells. American journal of physiology. Cell physiology 306, C648–658, https://doi.org/10.1152/ajpcell.00351.2013 (2014).
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer;Cancer Drug Resistance;2024-09-10
2. Targeting the CDK7-MDK axis to suppresses irinotecan resistance in colorectal cancer;Life Sciences;2024-09
3. Recent advances in minimally invasive biomarkers of OSCC: from generalized to personalized approach;Frontiers in Oral Health;2024-08-02
4. lncRNAs: New players of cancer drug resistance via targeting ABC transporters;IUBMB Life;2024-08
5. Monitoring melanoma patients on treatment reveals a distinct macrophage population driving targeted therapy resistance;Cell Reports Medicine;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3